SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Condor who wrote (5083)4/6/1999 2:24:00 PM
From: Rande Is  Read Replies (2) | Respond to of 57584
 
Almost looks better for Immucor than for BIPL. Not sure how to read that one. Perhaps William has a better perspective. He's closer to BIPL than I.



To: Condor who wrote (5083)4/6/1999 4:07:00 PM
From: Bucky Katt  Read Replies (2) | Respond to of 57584
 
Condor, the way I figure it, Biopool is now selling for cash on hand. This cannot last, the market is not that inefficient. There is a nice value play developing here, the only problem is this not a value market, but it should not diminish l/t prospects. Their products will be needed by an aging generation of baby boomers, and after the internet, biotech/health is the next big thing, IMO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News